Clinical Trial Update: Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating the addition of ruxolitinib to radiation and temozolomide for newly diagnosed glioblastoma. The study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Ruxolitinib (ruxolitinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Glioblastoma, Brain Cancer | Phase 2 | Status: RECRUITING